Ethanol is reinforcing within the nucleus accumbens shell (NACsh), but the underlying mechanisms remain unclear. Ethanol can potentiate the function of the GABA A , GABA B , and serotonin-3 (5-HT 3 ) receptors. Therefore, the current study tested the hypothesis that activation of these receptors would be involved in the reinforcing effects of ethanol in the NACsh. An intracranial self-administration (ICSA) procedure was used to assess the reinforcing effects of ethanol in the NACsh of alcohol preferring (P) rats. The ICSA consisted of seven sessions: four sessions to establish 150 mg% ethanol selfinfusion into the NACsh; sessions 5 and 6 with co-infusion of ethanol plus one concentration of the GABA A antagonist bicuculline (10 or 100 µM), the GABA B antagonist SCH 50911 (50, 75 or 100 µM), or the 5-HT 3 receptor antagonist zacopride (10 or 100 µM); and session 7 with 150 mg% ethanol alone. All groups self-infused ethanol into the NACsh and readily discriminated the active from inactive lever during the acquisition sessions. Coinfusion of 100 µM, but not 10 µM, bicuculline or zacopride significantly decreased active responses during sessions 5 and 6. Co-infusion of 75 µM, but not 50 or 100 µM, SCH 50911 significantly attenuated responses for ethanol. Overall, the results suggest that the reinforcing effects of ethanol in the NACsh may be modulated by activation of local GABA A , GABA B and 5-HT 3 receptors.
Introduction
Identification of brain reward mechanisms underlying the reinforcing effects of ethanol is critical to the development of effective therapies for combating alcohol abuse and alcoholism. A recent intracranial self-administration (ICSA) study demonstrated that ethanol can be readily self-infused into the nucleus accumbens (NAC) of the rat; the self-infusion was sub-region dependent with self-infusion into the NAC shell (NACsh) but not NAC core (NACcr), and genetically influenced with alcohol preferring (P) rats being more sensitive than stock Wistar rats to the rewarding effects of ethanol (Engleman et al., 2009 ). These findings suggest that the NACsh is one neuro-anatomical substrate supporting the reinforcing and rewarding effects of ethanol. However, neurochemical mechanisms underlying these effects remain unknown and elucidation of such mechanisms are important.
The NAC is a heterogeneous nucleus and approximately 90% of its neurons are gamma-aminobutyric acid (GABA) medium spiny neurons (MSNs); it receives synaptic inputs from various brain regions (Meredith 1999; Sesack and Grace 2010) . GABA synapses provide a major inhibitory regulation of MSN activity. These GABAergic inputs originate mainly from GABA neurons in the ventral tegmental area (VTA; Van Bockstaele and Pickel, 1995) and ventral pallidum (Groenewegen et al. 1999) , as well as intrinsic axonal collaterals from local MSNs (Meredith, 1999) . Moderate expression of both GABA A and GABA B receptors were found in the NAC (Bowery et al., 1987; Schwarzer et al., 2001 ). In addition, the NAC receives modulatory serotonin (5-HT) afferents from the dorsal raphe nucleus (Van Bockstaele and Pickel, 1993) . The presence of 5-HT receptors has been demonstrated in the NAC (Meredith, 1999) , including the serotonin-3 (5-HT 3 ) receptor (Ge et al., 1997) . The interactions between GABA/5-HT and their respective receptors play an important role in regulating the MSN activity and other neurotransmitter systems converging on the NAC (Meredith, 1999) . It has been proposed that the rewarding information is encoded in the activity of MSNs in the NAC and forwarded to downstream structures including the ventral pallidum (Carlezon and Thomas, 2009) .
Substantial evidence suggests that GABA neurotransmission is involved in the effects of ethanol (Koob, 2004) . Electrophysiological studies indicate that acute ethanol can potentiate GABA A -and GABA B -receptor mediated inhibitory currents (Allan et al., 1987; Federici et al., 2009; Grobin et al., 1998) . Systemic administration of GABA A receptor antagonists or an inverse benzodiazepine agonist reduced voluntary alcohol drinking and the motivation in rats to respond for ethanol self-administration in an oral operant setting (McBride et al., 1988; Petry, 1997; Rassnick et al., 1993; Samson et al., 1987) . GABA A receptors within the mesolimbic system appeared to mediate such effects (Hodge et al., 1995; Hyytia and Koob, 1995) . Similarly, pharmacological manipulations of GABA B receptor activity can regulate the reinforcing and rewarding effects of ethanol (Maccioni and Colombo, 2009; Vlachou and Markou, 2010) . In addition, acute ethanol can facilitate 5-HT 3 receptormediated ion currents (Lovinger and White, 1991) . The 5-HT 3 receptor has been implicated in the effects of drugs of abuse (Engleman et al., 2008) . Systemic administration of 5-HT 3 receptor antagonists suppressed voluntary ethanol consumption in rats under 24-hour free-choice conditions (Knapp and Pohorecky, 1992; McKinzie et al., 1998) . Nonetheless, the involvement of these receptors in the local reinforcing effects of ethanol within the NACsh has not been examined. Given the above-mentioned findings, it is possible that activation of these receptors may be involved in mediating the self-infusion of ethanol into the NACsh. The current study was designed to test this hypothesis by examining local self-infusion of ethanol in the presence of antagonists for these receptors.
Materials and methods
Experimentally-naïve adult female alcohol P rats (body weight 250-300 g, Indiana University, USA) were housed in-pairs in a reverse 12-hour light-dark cycle room (light off at 10:00) with temperature and humidity maintained constant for at least two weeks before the commencement of experiment. Food and water were available ad libitum except during the ICSA test sessions. Female rats were used in the present study due to their ability to maintain their head size better than male rats for more accurate stereotaxic placements Rodd-Henricks et al., 2000a) . The estrous cycle was not monitored in the present study. Experiments were performed during the dark phase. Protocols used were approved by the Institutional Animal Care and Use Committee of Indiana University School of Medicine. All experiments were performed in accordance with the principles outlined in the Guide for the Care and Use of Laboratory Animals (National Research Council, 2011) .
Chemical agents
The artificial cerebrospinal fluid (aCSF) consisted of 120 mM NaCl, 4.8 mM KCl, 1.2 mM KH 2 PO 4 , 1.2 mM MgSO 4 , 25 mM NaHCO 3 , 1.2 mM CaCl 2 , 10 mM d-glucose, pH 7.2-7.4. Ethyl alcohol (190 proof) was obtained from Decon Laboratories, Inc., (King of Prussia, Pennsylvania, USA). The GABA A receptor antagonist bicuculline, the GABA B receptor antagonist SCH 50911 (Bolser et al., 1995) , and the 5-HT 3 receptor antagonist zacopride were obtained from Tocris (Ellisville, Missouri, USA). All chemicals were dissolved in the aCSF solution to the desired concentrations prior to use.
Stereotaxic surgery procedures
Rats were implanted unilaterally with a 22-gauge cannula (Plastics One Inc., Roanoke, Virginia, USA) aimed at the right NACsh (AP+1.7 mm, ML+2.4 mm, DV-7.0 mm), as described previously (Engleman et al., 2009) . Stylets were inserted into cannulae when no experiments were being conducted. Rats were individually housed after surgery and were allowed to recover from surgery for at least seven days prior to tests. Rats were habituated and handled on a daily basis during the seven-day period.
ICSA procedure
The ICSA tests followed procedures previously described Engleman et al., 2009) . Briefly, rats were placed into standard two-lever operant chambers on test days. One active lever was connected to an isolated pulse stimulator (A-M Systems, Inc., Carlsborg, Washington State, USA) controlled by an operant control system Graphic State 3.02 (Coulbourn Instruments, Allentown, Pennsylvania, USA). The pulse stimulator was connected to two electrodes that were immersed in a drug-filled tank equipped with a 28-gauge injection cannula inserted into the NACsh. Each response on the active lever (fixed ratio 1 (FR1) reinforcement schedule) produced a pulse infusion of 100 nL of solution into the NACsh during a five-second period. Each infusion was followed by a five-second timeout period. During both the infusion and timeout periods, responses on the active lever were recorded but did not produce further infusions. The responses on the inactive lever were recorded but did not result in any infusions. The assignment of active and inactive lever was counterbalanced among rats.
There were a total of seven sessions conducted every other day with the duration of each session being four hours. The first four sessions were acquisition sessions with 150 mg% ethanol available for self-infusion for each rat. This concentration of ethanol is physiologically relevant and can be readily achieved with free-choice voluntary drinking by P rats (Murphy et al., 1986) . In addition, this concentration of ethanol was demonstrated to be the optimal concentration for self-infusion into the NACsh by P rats (Engleman et al., 2009) . Sessions 5 and 6 were co-infusion sessions, during which 150 mg% ethanol plus one concentration of the GABA A antagonist bicuculline (10 or 100 µM), the GABA B receptor antagonist SCH 50911 (50, 75 or 100 µM), or the 5-HT 3 receptor antagonist zacopride (10 or 100 µM) was self-infused. Session 7 was a session with the return of selfinfusion of only 150 mg% ethanol. This procedure has been carried out in the past to examine receptor mechanisms involved in ethanol ICSA within the posterior VTA (Ding et al., 2012; RoddHenricks et al., 2003) . In addition, the Engleman et al. study (2009) showed that replacement of ethanol with aCSF during sessions 5 and 6 resulted in extinction of lever responding. Therefore, such a group was not included in the current study.
Histology
At the end of the experiments, rats were euthanized and bromophenol blue was injected into the NACsh, as described previously (Engleman et al., 2009 ). Brains were quickly removed and frozen at -20 o C. Brain sections (40 µm thick) were sliced in a cryostat microtome and stained with cresyl violet for the verification of the placement of injection sites according to the rat brain atlas of Paxinos and Watson (1998) .
Statistical analysis
For each group, lever discrimination was determined by 'lever (active vs inactive)×session' mixed analysis of variance (ANOVA) with repeated measures on session; t-tests were used to compare responses between active and inactive lever following a significant main effect (p<0.05). For determination of drug effect, paired t-tests were used to compare the responses on the active lever and number of infusions during sessions 5 and 6 to average responses on the active lever and number of infusions during acquisition sessions 3 and 4.
Results
Figure 1 depicts the representative non-overlapping placements of injection sites within the NACsh. A majority of injection sites were located in the medial and ventral portions of the NACsh. Only rats with correct placements in the NACsh were included in analysis. There were six rats with injection sites ventral to the NACsh (Figure 1 ). These rats displayed low responses on active and inactive levers (8±2 vs 5±1 responses/session, respectively), as well as low infusions per session (5±1). These results, along with the previous study (Engleman et al., 2009) , suggest that adjacent areas outside the NACsh do not support the self-infusion of ethanol.
Lever responses for the bicuculline co-infusion groups are shown in Figure 2 . The 'lever×session' mixed ANOVAs indicated that the control group (Figure 2 , upper panel) demonstrated a significant effect of lever (F 1,12 =20.3, p=0.001) and interaction (F 6,72 =2.8, p=0.02) , but no effect of session (F 6,72 =1.3, p=0.28) . Lever discrimination was observed during sessions 3 through 7.
The 10 µM bicuculline group demonstrated significant effects of session (F 6,60 =5.3, p<0.001) , lever (F 1,10 =21.2, p=0.001) and interaction (F 6,60 =2.5, p=0.03) . Lever discrimination was observed during each session. Microinjection of 10 µM bicuculline did not significantly reduce responses on the active lever (Figure 2 , middle panel, e.g. responses in session 6 vs average during sessions 3 and 4: 36±6 vs 42±5, t 5 =0.9, p=0.39) or number of infusions (Table 1) during either treatment session. The significant effects of session and interaction resulted mainly from the significant difference in responses on the active lever between session one and the other sessions. The 100 µM bicuculline group (Figure 2 , bottom panel) demonstrated significant effects of session (F 6,60 =11.7, p<0.001), lever (F 1,10 =21.2, p=0.001), and interaction (F 6,60 =9.0, p<0.001). Lever discrimination was evident during sessions 1-4, and session 7. Co-infusion of 100 µM bicuculline with ethanol significantly depressed responses on the active lever (e.g. responses in session 6 vs average during sessions 3 and 4: 13±3 vs 35±2, t 5 =7.4, p=0.001) and number of infusions (Table 1) during both treatment sessions. Responses on the active lever during session 7 returned to levels observed during the acquisition sessions.
Lever responses in the SCH 50911 co-infusion groups are shown in Figure 3 . The 50 µM SCH 50911 group (Figure 3 , upper panel) demonstrated significant effects of session (F 6,60 =4.7, p=0.001), lever (F 1,10 =13.8, p=0.004) and interaction (F 6,60 =2.5, p=0.03). Lever discrimination was observed during sessions 3-5, and 7. SCH 50911 at 50 µM slightly reduced active responses during session 6. The 75 µM SCH 50911-treated group demonstrated significant effects of session (F 6,60 =3.8, p=0.003) , lever (F 1,10 =8.3, p=0.02) and interaction (F 6,60 =5.3, p<0.001) . Lever discrimination was observed during sessions 3, 4, and 7. Co-infusion of 75 µM SCH 50911 with ethanol significantly depressed responses on the active lever during both co-infusion sessions (Figure 3 , middle panel, e.g. responses during session 6 vs average during sessions 3 and 4: 13±2 vs 33±4, t 5 =5.3, p=0.003). The number of infusions was also reduced ( Table 1) . The 100 µM SCH 50911 group (Figure 3 , bottom panel) demonstrated significant effects of session (F 6,60 =2.9, p=0.02), lever (F 1,10 =18.9, p=0.001), but no significant effect of interaction (F 6,60 =0.8, p=0.79) . Lever discrimination was observed during sessions 3, 4 and 7. Co-infusion of 100 µM SCH 50911 did not significantly alter responses on the active lever during either coinfusion session (e.g. responses during session 6 vs average during sessions 3 and 4: 36±3 vs 49±10, t 5 =1.2, p=0.29). However, co-infusion of 100 µM SCH 50911 disrupted lever discrimination during both treatment sessions, as a result of a trend to increase responses on the inactive lever (Figure 3, bottom panel) .
Lever responses in the zacopride co-infusion groups are shown in Figure 4 Effects of co-infusion of artificial cerebrospinal fluid (aCSF), 10 or 100 µM bicuculline (a GABA A receptor antagonist) with 150 mg% ethanol (EtOH) on lever responses for the intracranial self-infusion of ethanol into the nucleus accumbens shell (n=6-7 per group). *p<0.05, significantly higher responses than those on the inactive lever. #p<0.05, significantly lower responses than the average responses on the active lever during acquisition sessions 3 and 4.
p=0.002), but no significant effect of session (F 6,72 =1.1, p=0.35) or interaction (F 6,72 =0.15, p=0.99) . Lever discrimination was observed during sessions 1-4, and session 6. Co-infusion of 10 µM zacopride did not significantly alter responses on the active lever (e.g. responses during session 6 vs average during sessions 3 and 4: 27±5 vs 32±2, t 6 =1.0, p=0.34) or number of infusions (Table 1) in either co-infusion session. The 100 µM zacopride group demonstrated significant effects of session (F 6,60 =5.8, p<0.001), lever (F 1,10 =32.3, p<0.001) and interaction (F 6,60 =6.3, p<0.001). Lever discrimination was observed during sessions 2-4 and 7. Co-infusion of 100 µM zacopride with ethanol significantly decreased responses on the active lever (Figure 4 , bottom panel, e.g. responses during session 6 vs average during sessions 3 and 4: 16±2 vs 34±3, t 5 =7.1, p=0.001) and number of infusions (Table 1) during both co-infusion sessions. Responses on the active lever returned to baseline levels during session 7.
Discussion
The major findings of the current study are that co-infusion of antagonists for the GABA A , GABA B or 5-HT 3 receptor with ethanol attenuated the responses on the active lever and the selfinfusion of ethanol into the NACsh, suggesting that the reinforcing effects of ethanol in the NACsh may be mediated, at least in part, by activating local GABA A , GABA B and 5-HT 3 receptors. None of the antagonists, at any concentration, appeared to reduce responses on the inactive lever. These results suggest that a general effect of motor impairment cannot account for the reduced responses on the active lever. In addition, the highest concentration of the GABA B receptor antagonist disrupted lever discrimination mainly by increasing the responses on the inactive lever, which suggests a non-specific effect of the antagonist at this concentration.
The finding with bicuculline is in agreement with previous studies demonstrating that both systemic administration (McBride et al., 1988; Petry, 1997; Samson et al., 1987) and local microinjection of GABA A receptor antagonists into the NACsh (Hyytia and Koob, 1995) impaired oral ethanol self-administration in the rat. Another study (Hodge et al., 1995) also indicated that microinjection of bicuculline into the NAC reduced oral ethanol self-administration, although a detailed histological map of injection sites was not presented. In addition, bicuculline did not significantly alter responses on the inactive lever (Figure 2) , suggesting the effects of bicuculline may not involve alteration of locomotor activity. Moreover, a previous study (Znamensky et al., 2001 ) demonstrated that bilateral microinjection of bicuculline (up to 1.6 mM) into the NACsh did not significantly alter food intake in the rat, providing support that bicuculline is not impairing general motor activity. Taken together, these findings indicate the important role of NACsh GABA A receptors in modulating the local positive motivational properties of ethanol (Koob, 2004) . A recent study using a similar ICSA procedure indicated that co-infusion of bicuculline with ethanol did not appear to alter ethanol self-infusion directly into the posterior VTA (Ding et al., 2011) . These results suggest that local GABA A receptors may be differentially involved in ethanol self-infusion between the posterior VTA and NACsh.
In addition, these findings are in line with in vitro electrophysiological studies demonstrating that ethanol can potentiate GABA A receptor-mediated currents (Allan et al., 1987) . In the NAC, ethanol may potentiate GABA A receptor function through both pre-and post-synaptic mechanisms (Weiner and Valenzuela, 2006) . In a NAC slice preparation, application of ethanol produced a dose-dependent enhancement of GABA A receptor-mediated currents in a subpopulation of NAC neurons; the optimal concentration of ethanol (44 mM or ~ 200 mg%) was comparable to that used in the current study (150 mg%) and increased GABA A current amplitude by approximately 40% in about 45% of neurons examined (Nie et al., 2000) . Furthermore, ethanol was shown to increase presynaptic GABA release in the NAC slice (Weiner and Valenzuela, 2006) . Therefore, the net effect of ethanol through the GABA A receptor on these MSNs may be an enhanced inhibition of their activity and reduce GABA release in the ventral pallidum. In line with this idea, previous findings indicated that ethanol administration decreased spike activity in approximately 30% of NAC neurons, and reduced extracellular GABA levels in the ventral pallidum (Janak et al., 1999; Kemppainen et al., 2010) . It should be noted that the exact location of ethanol-sensitive GABA A receptors within the NAC subregions remains unknown in these electrophysiological studies due to the lack of detailed histological presentation of electrode placements. Furthermore, GABA A receptor subunits were also found in non-GABAergic interneurons and axonal processes converging on the NAC (Schwarzer et al., 2001 ). Activation of these receptors can modulate release of acetylcholine, GABA and/or dopamine (Aono et al., 2008; Rada et al., 1993; Yoshida et al., 1997) , and differentially alter the activity of MSNs. For example, activation of these receptors on GABAergic terminals may inhibit GABA release, resulting in attenuated inhibition of post-synaptic MSNs. Indeed, ethanol was shown to decrease GABA A -mediated currents and increase the excitability of a subpopulation of NAC neurons (Janak et al., 1999; Nie et al., 2000) . Moreover, the sensitivity of GABA A receptors to ethanol enhancement depends on the subunit compositions of the GABA A receptor (Kumar et al., 2009) , which are heterogeneously expressed within the NAC (Schwarzer et al., 2001) . Therefore, the action of ethanol on MSNs depends on micro-circuits within the NAC that may differ in the relative location of GABA A receptors and their subunit composition. Taken together, it is possible that multiplex mechanisms may contribute to the self-infusion of ethanol and the effects of bicuculline on ethanol self-infusion into the NACsh. Similar to GABA A receptors, activation of local GABA B receptors appeared to mediate the reinforcing effects of ethanol within the NACsh, as indicated by the results that 75 µM SCH 50911 attenuated ethanol self-infusion. This finding is consistent with in vitro evidence that the GABA B receptor-mediated inhibitory postsynaptic potential is sensitive to ethanol potentiation (Federici et al., 2009) . The highest concentration of SCH 50911 disrupted lever discrimination between the active and inactive levers due in Figure 4 . Effects of co-infusion of 10 or 100 µM zacopride (a 5-HT3 receptor antagonist) with 150 mg% ethanol (EtOH) on lever responses for the intracranial self-infusion of ethanol into the nucleus accumbens shell (n=6-7 per group). *p<0.05, significantly higher responses than those on the inactive lever. #p<0.05, significantly lower responses than the average responses on the active lever during acquisition sessions 3 and 4.
part to increased responding on the inactive lever (Figure 3 , bottom panel). These results suggest possible non-specific actions of SCH 50911. The mechanism underlying these effects are unknown, but may be due to different subtypes of GABA B receptors, GABA B receptors being located on both pre-and post-synaptic membrane, and multiple actions of SCH 50911 occurring at the highest concentration. For example, a high concentration of SCH 50911 was shown to act as an inverse agonist for the GABA B receptor to increase 3'-5'-cyclic adenosine monophosphate (cAMP) production in a cell culture (Grunewald et al., 2002) .
In addition to the GABA receptors, activation of local 5-HT 3 receptors also appeared to be involved in mediating the reinforcing effects of ethanol, as suggested by the findings that co-infusion of zacopride with ethanol dampened ethanol self-infusion into the NACsh. A previous study (Herges and Taylor, 2000) showed that antagonism of 5-HT 3 receptors within the NAC with ondansetron did not significantly alter basal locomotor activity. In addition, zacopride did not appear to alter responses on the inactive lever in the current study (Figure 4 ). All these findings suggest that the effects of zacopride may not involve impairment of locomotor activity. This finding is in line with electrophysiological findings that ethanol can potentiate 5-HT 3 receptor mediated currents in vitro (Lovinger and White, 1991; Machu and Harris, 1994) . Our results provide mechanistic evidence supporting the involvement of activation of NACsh 5-HT 3 receptors in mediating systemic ethanol self-administration in rodents (Engleman et al., 2008; Knapp and Pohorecky, 1992; McKinzie et al., 2000; Rodd-Henricks et al., 2000b) . Interestingly, local 5-HT 3 receptors within the VTA also seem to be involved in the reinforcing and rewarding effects of ethanol (Rodd-Henricks et al., 2003; Rodd et al., 2010) . These studies suggest a close relationship between ethanol self-administration and 5-HT 3 receptors within the mesolimbic system. Autoradiographic studies indicated that low to moderate densities of 5-HT 3 receptor binding sites were present in the NAC (Barnes et al., 1990; Ge et al., 1997; Kilpatrick et al., 1987) . However, the relative cellular location and distribution in each NAC sub-region of these receptors remains unclear. In situ hybridization studies (Morales et al., 2004; Tecott et al., 1993) did not detect 5-HT 3 receptor mRNA in the NAC, which agrees with an immunocytochemistry study showing that very low levels of 5-HT 3 receptor-expressing cells were detected in the NAC (Morales et al., 1998) . These studies suggest that these receptors may be preferentially localized on synaptic terminals as opposed to NAC MSNs. One likely possibility is on dopaminergic terminals. Microdialysis studies demonstrated that local perfusion of a 5-HT 3 receptor agonist could increase basal and ethanol-evoked dopamine release in the NAC, whereas antagonizing local 5-HT 3 receptors could attenuate ethanol-induced dopamine release in the NAC (Campbell and McBride, 1995) . In addition, systemic administration of 5-HT 3 receptor antagonists was shown to attenuate ethanolinduced dopamine release in the NAC (Carboni et al., 1989; Wozniak et al., 1990) . These findings suggest that 5-HT 3 receptors on dopaminergic terminals may contribute to ethanol self-infusion and the effects of zacopride observed in the current study.
In summary, the current study demonstrated that antagonism of local GABA A , GABA B or 5-HT 3 receptors attenuated ethanol selfinfusion into the NACsh, suggesting that the local reinforcing effects of ethanol in the NACsh may be mediated by activation of these receptors. These results are consistent with previous findings and suggest these receptors within the NACsh may contribute to the global reinforcing and rewarding effects of ethanol. On the other hand, it remains unknown whether there are possible interactions among these different receptors and how they interact in mediating ethanol reinforcement, which warrants future studies.
